MDP:CC News and Press, Medexus Pharmaceuticals Inc. From 11/21/23

Alvopetro Energy Ltd. (ALV:CA) is expected to report $0.23 for Q3 2023 Martello Technologies Group Inc. (MTLO:CA) is expected to report for quarter end 2023-09-30 George Weston Limited (WN:CA) is expected to report for Q3 2023 EQB Inc. (EQB:CA) is expected to report $2.85 for Q3 2023 ...

Slate Office REIT (SOT.UN:CA) is expected to report $0.09 for Q3 2023 Excellon Resources Inc. (EXN:CA) is expected to report for Q1 2024 High Arctic Energy Services Inc. (HWO:CA) is expected to report for Q1 2024 Medexus Pharmaceuticals Inc. (MDP:CA) is expected to report $0.02 for Q2...

Medexus Pharmaceuticals Inc. (MDP:CA) is expected to report $0.02 for Q2 2024

Fiscal Q2 2024 revenue reflects a 9.4% increase over fiscal Q2 2023, demonstrating strong revenue growth and continued overall performance Management to host conference call at 8:00 AM Eastern time on Thursday, November 9, 2023 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - Novemb...

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 1, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, November 9, 2023 to discuss Medexus's results for its second fiscal quarter ended September 30, ...

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 17, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that, in connection with its recently completed bought-deal public offering ( Offering ) of units ( Units ), Medexus has issued an additional 508,...

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 16, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) has made in cash the final maturity date payment of C$51.1 million (or approximately US$37.5 million) to Computershare Trust Company of Canada as trustee for holders of ...

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 6, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the closing of its bought-deal public offering of 3,389,900 units ( Units ) at a price of C$2.95 per Unit for aggregate gross proceeds to Medexus o...

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 28, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the company recently entered into a third amendment to its February 2021 exclusive license agreement with medac GmbH relating to commercial...

All director nominees reelected and all other company proposals approved by shareholders Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 21, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today held its virtual annual meeting of shareholders. Medexus shareholders e...